Form 8-K BIOLASE, INC For: Aug 07

Go back to Form 8-K BIOLASE, INC For: Aug 07

Biolase Technology, Inc. (BIOL) Misses Q2 EPS by 9c

August 7, 2014 4:18 PM EDT

Biolase Technology, Inc. (NASDAQ: BIOL) reported Q2 EPS of ($0.17), $0.09 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $10.2 million versus the consensus estimate of $12.97 million.

For earnings history and earnings-related data on Biolase Technology, Inc. (BIOL) click here.

... More